The antibody response in human autoimmune thyroid disease

Clinical Science

Volumn 92, Issue 6, 1997, Pages 529-541

  McIntosh, Richard S ^a,b   Asghar, M Suhail ^a   Weetman, Anthony P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Autoantibodies; Autoimmunity; B lymphocytes; Combinatorial library; Graves' disease; Hashimoto's thyroiditis; Monoclonal antibody; Repertoire development; Thyroglobulin; Thyroid peroxidase; Thyroid stimulating hormone receptor

Indexed keywords

AUTOANTIGEN; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN LIGHT CHAIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY STRUCTURE; AUTOIMMUNITY; BACTERIOPHAGE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; ETIOLOGY; GRAVES DISEASE; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; THYROID DISEASE;

EID: 0030989993     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920529     Document Type: Review

References (110)

1. Hafler DA, Weiner HL. Antigen-specific therapies for the treatment of autoimmune diseases. Springer Semin Immunopathol 1995; 17: 61-76.
2. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15: 788-830.
3. Köhler G, Milstein, C. Continuous cultures of fused cells secreting antibody of predetermined specificity. Nature (London) 1975; 256: 495-7.
4. Casali P, Inghirami G, Nakamura M, Davies TF, Notkins AL. Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV. Science 1986; 234: 476-9.
5. Petersen VB, Fukuma N, McLachlan SM, et al. A human-mouse hybridoma which secretes monoclonal thyroglobulin autoantibody with properties similar to those of the donor patient's serum autoantibody. Autoimmunity 1989; 4: 89-102.
6. Fukuma N, Petersen VB, McLachlan SM, Pegg CAS, Rees Smith B. Human monoclonal thyroglobulin autoantibodies of high affinity. I. Production, characterization and interaction with murine monoclonal thyroglobulin antibodies. Autoimmunity 1991; 10: 291-5.
7. Prentice L, Kiso Y, Fukuma N, et al. Monoclonal thyroglobulin autoantibodies: variable region analysis and epitope recognition. J Clin Endocrinol Metab 1995; 80: 977-86.
8. Horimoto M, Peterson VB, Pegg CAS, et al. Production and characterization of a human monoclonal thyroid peroxidase autoantibody. Autoimmunity 1992; 14: 1-7.
9. Burton DR, Barbas III CF. Human antibodies from combinatorial libraries. Adv Immunol 1994; 57: 191-280.
10. Rapoport B, Portolano S, McLachlan SM. Combinatorial libraries: new insights into human organ-specific autoantibodies. Immunol Today 1995; 16: 43-9.
11. McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 1992; 13: 192-206.
12. Nagayama Y. Continuous versus discontinuous B-cell epitopes on thyroid-specific autoantigens: thyrotropin receptor and thyroid peroxidase. Eur J Endocrinol 1995; 132: 9-11.
13. Rapoport B, McLachlan SM, Kakinuma A, Chazenbalk GD. Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate. J Clin Endocrinol Metab 1996; 81: 2525-33.
14. Pauls DL, Zakarija M, McKeraie JM, Egeland JA. Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families. Am J Med Genet 1993; 47: 375-9.
15. Phillips DIW, Shields DC, Dugoujon JM, Prentice L, McGuffin P, Rees Smith B. Complex segregation analysis of thyroid autoantibodies: are they inherited as an autosomal dominant trait? Hum Hered 1993; 43: 141-6.
16. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990; 8: 773-93.
17. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993; 178: 1459-63.
18. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181: 1957-64.
19. Chazenbalk GD, Portolano S, Russo D, Hutchison JS, Rapoport B, McLachlan SM. Human organ-specific autoimmune disease. Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ. J Clin Invest 1993; 92: 62-74.
20. Costante G, Portolano S, Nishikawa T, et al. Recombinant thyroid peroxidase-specific autoantibodies. II. Role of individual heavy and light chains in determining epitope recognition. Endocrinology 1994; 135: 25-30.
21. Roitt IM, Doniach D, Campbell PN, Vaughan Hudson R. Autoantibodies in Hashimoto's disease (lymphadenoid goitre). Lancet 1956; ii: 820-1.
22. Beever K, Bradbury J, Phillips D, et al. Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 1989; 35: 1949-54.
23. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43: 55-68.
24. Nordyke RA, Gilbert Jr FL, Miyamoto LA, Fleury KA. The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Internal Med 1993; 153: 862-5.
25. Weetman AP, Black CM, Cohen SB, Tomlinson R, Banga JP, Reimer CB. Affinity purification of IgG subclasses and the distribution of thyroid autoantibody reactivity in Hashimoto's thyroiditis. Scand J Immunol 1989; 30: 73-82.
26. Ruf J, Feldt-Rasmussen U, Hegedüs L, Ferrand M, Carayon P. Bispecific thyroglobulin and thyroperoxidase autoantibodies in patients with various thyroid and autoimmune diseases. J Clin Endocrinol Metab 1994; 79: 1404-9.
27. Hexham JM, Furmaniak J, Pegg C, Burton DR, Rees Smith B. Cloning of a human autoimmune response: preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach. Autoimmunity 1992; 12: 135-41.
28. McIntosh RS, Tandon N, Metcalfe RA, Weetman AP. Cloning and analysis of IgM anti-thyroglobulin autoantibodies from patients with Hashimoto's thyroiditis. Biochim Biophys Acta Mol Basis Dis 1994; 1227: 171-6.
29. McIntosh RS, Asghar MS, Watson PF, Kemp EH, Weetman AP. Cloning and analysis of IgGκ and IgGλ anti-thyroglobulin autoantibodies from a patient with Hashimoto's thyroiditis: evidence for in wo antigen-driven repertoire selection. J Immunol 1996; 157: 927-35.
30. Caturegli P, Kuppers RC, Mariotti S, et al. IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 1994; 98: 464-9.
31. Fukuma N, McLachlan SM, Petersen VB, et al. Human thyroglobulin autoantibodies of subclasses IgG2 and IgG4 bind to different epitopes on thyroglobulin. Immunology 1989; 67: 129-31.
32. Pascual V, Capra JD. Human immunoglobulin heavy chain variable region genes: organization, polymorphism, and expression. Adv Immunol 1991; 49: 1-74
33. Avrameas S, Ternynck T. Natural autoantibodies: the other side of the immune system. Res Immunol 1995; 146: 235-48.
34. Ichiyoshi Y, Zhou M, Casali P. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific 'germ-line' natural antibody template: analysis by V gene segment reassortment and site-directed mutagenesis. J Immunol 1995; 154: 226-38.
35. Gilbert D, Brard F, Margarine C, Delpech A, Tron F. An idiotype D23-bearing polyspecific, murine anti-DNA monoclonal antibody forms glomerular immune deposits: pathogenic role of natural autoantibodies? Mol Immunol 1995; 32: 477-86.
36. Saboori AM, Caturegli P, Rose NR, Mariotti S, Pinchera A, Burek CL. Tryptic peptides of human thyroglobulin. II. Immunoreactivity with sera from patients with thyroid diseases. Clin Exp Immunol 1994; 98: 459-63.
37. Saboori AM, Rose NR, Burek CL. Amino acid sequence of a tryptic peptide of human thyroglobulin reactive with sera of patients with thyroid diseases. Autoimmunity 1995; 22: 87-94.
38. Henry M, Malthiery Y, Zanelli E, Charvet B. Epitope mapping of human thyroglobulin: Heterogeneous recognition by thyroid pathologic sera. J Immunol 1990; 145: 3692-8.
39. Tonacchera M, Cetani F, Costagliola S, et al. Mapping thyroid peroxidase epitopes using recombinant protein fragments. Eur J Endocrinol 1995; 132: 53-61.
40. Weetman AP, Cohen SB, Oleesky DA, Morgan BP. Terminal complement complexes and CI/CI inhibitor complexes in autoimmune thyroid disease. Clin Exp Immunol 1989; 77: 25-30.
41. McLachlan SM, Rapoport B. Genetic and epitopic analysis of thyroid peroxidase (TPO) autoantibodies: markers of the human thyroid autoimmune response. Clin Exp Immunol 1995; 101: 200-6.
42. Portolano S, Seto P, Chazenbalk GD, Nagayama Y, McLachlan SM, Rapoport B. A human Fab fragment specific for thyroid peroxidase generated by cloning thyroid lymphocyte-derived immunoglobulin genes in a bacteriophage lambda library. Biochem Biophys Res Commun 1991; 179: 372-7.
43. Portolano S, Chazenbalk GD, Seto P, Hutchison JS, Rapoport B, McLachlan SM. Recognition by recombinant autoimmune thyroid disease-derived Fab fragments of a dominant conformational epitope on human thyroid peroxidase. J Clin Invest 1992; 90: 720-6.
44. Portolano S, Chazenbalk GD, Hutchison JS, McLachlan SM, Rapoport B. Lack of promiscuity in autoantigen-specific H and L chain combinations as revealed by human H and L chain 'roulette'. J Immunol 1993; 150: 880-7.
45. Portolano S, McLachlan SM, Rapoport B. High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies. J Immunol 1993; 151: 2839-51.
46. Prummel MF, Portolano S, Costante G, Rapoport B, McLachlan SM. Isolation and characterization of a monoclonal human thyroid peroxidase autoantibody of lambda light chain type. Mol Cell Endocrinol 1994; 102: 161-6.
47. Portolano S, Prummel MF, Rapoport B, McLachlan SM. Molecular cloning and characterization of human thyroid peroxidase autoantibodies of lambda light chain type. Mol Immunol 1995; 32: 1157-69.
48. Hexham JM, Partridge LJ, Furmaniak J, et al. Cloning and characterisation of TPO autoantibodies using combinatorial phage display libraries. Autoimmunity 1994; 17: 167-79.
49. Hexham JM, Pegg CAS, Burton DR, et al. Variable region sequence of a human monoclonal thyroid peroxidase autoantibody. Autoimmunity 1992; 14: 169-72.
50. Parkes AB, McLachlan SM, Bird P, Rees Smith B. The distribution of microsomal and thyroglobulin activity among IgG subclasses. Clin Exp Immunol 1984; 57: 239-43.
51. Matsuda F, Honjo T. Organization of the human immunoglobulin heavy-chain locus. Adv Immunol 1996; 62: 1-29.
52. Stollar BD. The expressed heavy chain V gene repertoire of circulating B cells in normal adults. Ann NY Acad Sci 1995; 764: 265-74.
53. Klein R, Zachau HG. Expression and hypermutation of human immunoglobulin κ genes. Ann NY Acad Sci 1995; 764: 74-83.
54. Sanz I. Multiple mechanisms participate in the generation of diversity of human H-chain CDR3 regions. J Immunol 1991; 147: 1720-9.
55. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G. Preferential utilization of specific immunoglobulin heavy-chain diversity and joining segments in adult human peripheral-Wood B lymphocytes. J Exp Med 1991; 173: 395-407.
56. Jaume JC, Costante G, Portolano S, McLachlan SM, Rapoport B. Recombinant thyroid peroxidase-specific autoantibodies. I. How diverse is the pool of heavy and light chains in immunoglobulin gene libraries constructed from thyroid tissue-infiltrating plasma cells? Endocrinology 1994; 135: 16-24.
57. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P. Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583-91.
58. Kurosawa Y, Tonegawa S. Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. J Exp Med 1982; 155: 201-218.
59. Meek KD, Hasemann CA, and Capra JD. Novel rearrangements at the immunoglobulin D locus. Inversion and fusions add to IgH somatic diversity. J Exp Med 1989; 170: 39-57.
60. Shin EK, Akamizu T, Matsuda F, et al. Variable regions of Ig heavy chain genes encoding antithyrotropin receptor antibodies of patients with Graves' disease. J Immunol 1994; 152: 1485-92
61. Ruf J, Toubert M-E, Czarnocka B, Durand-Gorde J-M, Ferrand M, Carayon P. Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 1989; 125: 1211-8.
62. Czarnocka B, Pastuszko D, Carayon P, Ruf J, Gardas A. The majority of thyroid peroxidase autoantibodies in patients with autoimmune thyroid-disease are directed to a single TPO domain. Autoimmunity 1996; 23: 145-54.
63. Libert, F, Ludgate M, Dinsart C, Vassart G. Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector. J Clin Endocrinol Metab 1991; 73: 857-60.
64. Finke R, Seto P, Ruf J, Carayon P, Rapoport B. Determination at the molecular level of a B-cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 73: 919-21.
65. Jaume JC, Costante G, Nishikawa T, Phillips DIW, Rapoport B, McLachlan SM. Thyroid peroxidase autoantibody fingerprints in hypothyroid and euthyroid individuals. I. Cross-sectional study in elderly women. J Clin Endocrinol Metab 1995; 80: 994-9.
66. Jaume JC, Parkes AB, Lazarus JH, et al. Thyroid peroxidase autoantibody fingerprints. II. A longitudinal study in postpartum thyroiditis. J Clin Endocrinol Metab 1995; 80: 1000-5.
67. Jaume JC, Burek CL, Hoffmann WH, Rose NR, McLachlan SM, Rapoport B. Thyroid peroxidase autoantibody epitopic 'fingerprints' in juvenile Hashimoto's thyroiditis: Evidence for conservation over time and in families. Clin Exp Immunol 1996; 104: 115-23
68. Nishikawa T, Costante G, Prummel MF, McLachlan SM, Rapoport B. Recombinant thyroid peroxidase autoantibodies can be used for epitopic 'fingerprinting" of thyroid peroxidase autoantibodies in the sera of individual patients. J Clin Endocrinol Metab 1994; 78: 944-9.
69. Chazenbalk GD, Costante G, Portolano S, McLachlan SM, Rapoport B. The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope. J Clin Endocrinol Metab 1993; 77: 1715-8.
70. Nishikawa T, Rapoport B, McLachlan SM. The quest for the autoantibody immunodominant region on thyroid peroxidase: guided mutagenesis based on a hypothetical three-dimensional model. Endocrinology 1996; 137: 1000-6.
71. Nishikawa T, Nagayama Y, Seto P, Rapoport B. Human thyroid peroxidase-myeloperoxidase chimeric molecules: tools for the study of antigen recognition by thyroid peroxidase autoantibodies. Endocrinology 1993; 133: 2496-501.
72. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988; 9: 106-21.
73. Paschke R, van Sande J, Parma J, Vassart G. The TSH receptor and thyroid diseases. Ballière's Clin Endocrinol Metab 1996; 10: 9-27.
74. Worthington J, Byfield PGH, Himsworth RL. Heterogeneity of circulating TSH-receptor antibodies in thyroid disease demonstrated directly by chromatography. Clin Endocrinol (Oxford) 1991; 34: 147-54
75. Fan J-L, Desai RK, Dallas JS, Wagle NM, Seetharamaiah GS, Prabhakar BS. High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Clin Immunol Immunopathol 1994; 71: 69-74
76. Gupta MK. Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases. Clin Biochem 1992; 255: 193-9.
77. De Forteza R, Smith CU, Amin J, McKenzie JM, Zakarija M. Visualization of the thyrotropin receptor on the cell surface by potent autoantibodies. J Clin Endocrinol Metab 1994; 78: 1271-3.
78. McLachlan SM, Rapoport B. Monoclonal, human autoantibodies to the TSH receptor: the holy grail and why are we looking for it? J Clin Endocrinol Metab 1996; 81: 3152-4.
79. Drexhage HA. Autoimmunity and thyroid growth: where do we stand? Eur J Endocrinol 1996; 135: 39-45.
80. Zakarija M. Immunochemical characterisation of the thyroid-stimulating antibody in Graves' disease: evidence for restricted heterogeneity. J Clin Lab Immunol 1983; 10: 77-85.
81. Knight J, Laing P, Knight A, Adams D, Ling N. Thyroid-stimulating autoantibodies usually contain only λ-light chains: evidence for the 'forbidden clone' theory. J Clin Endocrinol Metab 1986; 62: 342-7.
82. Williams RC, Marshall NJ, Kilpatrick K, et al. Kappa/lambda immunoglobulin distribution of Graves' thyroid stimulating antibodies. Simultaneous analysis of C gene polymorphisms. J Clin Invest 1988; 82: 1306-12.
83. Weetman AP, Byfield PGH, Black C, Reimer CB. IgG heavy-chain subclass restriction of thyrotropin-binding inhibitory immunoglobulins in Graves' disease. Eur J Clin Invest 1990; 20: 406-10.
84. Dallas JS, Cunningham SJ, Patibandla SA, et al. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3′,5′-monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology 1996; 137: 3329-39.
85. Kraiem Z, Cho BY, Sadeh O, Shong MH, Pickerill P, Weetman AP. The IgG subclass distribution of TSH receptor blocking antibodies in primary hypothyroidism. Clin Endocrinol (Oxford) 1992; 37: 135-40.
86. Wadsworth HL, Chazenbalk GD, Nagayama Y, Russo D, Rapoport B. An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science 1990; 249: 1423-5.
87. Tahara K, Ban T, Minegishi T, Kohn LD. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 1991; 179: 70-7.
88. Kosugi S, Ban T, Akamizu T, Kohn LD. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema; these determinants have no homologous sequence on gonadotropin receptors. Mol Endocrinol 1992; 6: 168-80.
89. Kosugi S, Ban T, Kohn LD. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Mol Endocrinol 1993; 7: 114-30.
90. Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, Rapoport B. Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci USA 1991; 88: 902-5.
91. Nagayama Y, Russo D, Wadsworth HL, Chazenbalk GD, Rapoport B. Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. J Biol Chem 1991; 266: 14926-30.
92. Kosugi S, Ban T, Akamizu T, Kohn LD. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. Biochem Biophys Res Commun 1991; 180: 1118-24.
93. Kosugi S, Ban T, Akamizu T, Valente W, Kohn LD. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab 1993; 77: 19-24.
94. Nagayama Y, Rapoport B. Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser-25-Glu-30. J Clin Endocrinol Metab 1992; 75: 1425-30.
95. Ueda Y, Sugawa H, Akimizu T, et al. Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition. Eur J Endocrinol 1995; 132: 62-8.
96. Sugawa H, Akamizu T, Kosugi S, et al. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule. Eur J Endocrinol 1995; 133: 283-93.
97. Okuda J, Akamizu T, Sugawa H, Matsuda F, Hua L, Mori T. Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. J Clin Endocrinol Metab 1994; 79: 1600-4.
98. Li H, Akamizu T, Okuda J, et al. Isolation of Epstein-Barr-virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator: preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. Biochem Biophys Res Commun 1995; 207: 985-93.
99. Morgenthaler NG, Kim MR, Tremble J, et al. Human-immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity. J Clin Endocrinol Metab 1996; 81: 3155-61.
100. Huang GC, Collison KS, McGregor AM, Banga JP. Expression of a human thyrotrophin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves' disease. J Mol Endocrinol 1992; 8: 137-44.
101. Vlase H, Graves PN, Magnusson RP, Davies TF. Human autoantibodies to the thyrotropin receptor: recognition of linear, folded, and glycosylated recombinant extracellular domain. J Clin Endocrinol Metab 1995; 80: 46-53.
102. Morgenthaler NG, Tremble J, Huang GC, Scherbaum WA, McGregor AM, Banga JP. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. J Clin Endocrinol Metab 1996; 81: 700-6.
103. 35S-labelled TSH receptors produced in an in vitro transcription/ translation system. J Endocrinol Invest 1996; 19 (Suppl. 6): 16.
104. Huang GC, Page MJ, Nicholson LB, Collison KS, McGregor AM, Banga JP. The thyrotrophin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding. J Mol Endocrinol 1993; 10: 127-42.
105. Seetharamaiah GS, Desai RK, Dallas JS Tahara K Kohn LD, Prabhakar BS. Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. Autoimmunity 1993; 14: 315-20.
106. Misrahi M, Ghinea N, Sar S, et al. Processing of the precursors of the human thyroid-stimulating hormone receptor in various eukaryotic cells (human thyrocytes, transfected L cells and baculovirus-infected insect cells). Eur J Biochem 1994; 222: 711-9.
107. Seetharamaiah GS, Kurosky A, Desai RK, Dallas JS, Prabhakar BS. A recombinant extracellular domain of the thyrotropin (TSH) receptor binds TSH in the absence of membranes. Endocrinology 1994; 134: 549-54.
108. Chazenbalk GD, Rapoport B. Expression of the extracellular domain of the thyrotropin receptor in the baculovirus system using a promoter active earlier than the polyhedrin promoter. Implications for the expression of functional highly glycosylated proteins. J Biol Chem 1995; 270: 1543-9.
109. Harfst E, Johnstone AP, Nussey SS. Characterization of the extracellular region of the human thyrotropin receptor expressed as a recombinant protein. J Mol Endocrinol 1992; 9: 227-36.
110. Russo D, Chazenbalk GD, Nagayama Y, Wadsworth HL, Rapoport B. Site-directed mutagenesis of the human thyrotropin receptor: role of asparagine-linked oligosaccharides in the expression of a functional receptor. Mol Endocrinol 1991; 5: 29-33.